MISONIX, Inc. (MSON): Price and Financial Metrics


MISONIX, Inc. (MSON): $26.54

1.20 (+4.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MSON Stock Price Chart Interactive Chart >

Price chart for MSON

MSON Price/Volume Stats

Current price $26.54 52-week high $26.99
Prev. close $25.34 52-week low $11.04
Day low $25.08 Volume 158,800
Day high $26.56 Avg. volume 60,302
50-day MA $25.60 Dividend yield N/A
200-day MA $21.45 Market Cap 462.06M

MISONIX, Inc. (MSON) Company Bio


Misonix, Inc. produces and distributes medical devices. The Company offers devices for spinal decompression, wound management, tumor removal, and general surgery. Misonix markets its products in the United States.


MSON Latest News Stream


Event/Time News Detail
Loading, please wait...

MSON Latest Social Stream


Loading social stream, please wait...

View Full MSON Social Stream

Latest MSON News From Around the Web

Below are the latest news stories about Misonix Inc that investors may wish to consider to help them evaluate MSON as an investment opportunity.

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical outcomes, today announced that the stockholders of Bioventus approved the issuance of shares of Bioventus class A common stock to the stockholders of Mison

Yahoo | October 26, 2021

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (Misonix), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the Election Deadline) for stockholders of Misonix to elect the form of consideration they wish to receive for their shares of Misonix common stock in connection with the proposed merger of Oyster Merger Sub I, Inc., a newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub I), with and into Misonix, immediately followed by the merger of Misonix with and into Oyster Merger Sub II, LLC, another newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub II), pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated as of July 29,...

Intrado Digital Media | October 18, 2021

Radiofrequency Ablation System Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2021 – 2027 | Ethicon, Arthrex GmbH, Johnson & Johnson, Misonix, SonaCare Medical, Integra LifeSciences Corporat

The “Radiofrequency Ablation System Market” provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Market’s growth. The increase within the aviation sector is escalating the expansion

OpenPR | October 13, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, EBMT, MSON, NLOK; Shareholders are Encouraged to Contact the Firm

NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Hill-Rom Holdings, Inc. (NYSE: HRC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Baxter International Inc. for $156.00 per share in cash. If you are a Hill-Rom shareholder, click here to learn more about your rights and options. Eagle Bancorp Montana, Inc. (NASDAQ: EBMT

Yahoo | October 6, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MSON, RIVE, OSBC, IRT, ISBC; Shareholders are Encouraged to Contact the Firm

NEW YORK , Oct. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Misonix, Inc. (NASDAQ: MSON ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bioventus Inc. Under the terms of the agreement, Misonix stockholders may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. If you are a Misonix shareholder, click here to learn more about your rights and options . Full story available on Benzinga.com

Benzinga | October 4, 2021

Read More 'MSON' Stories Here

MSON Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 19.66%
3-year -1.56%
5-year 177.91%
YTD N/A
2021 0.00%
2020 -32.83%
2019 16.24%
2018 69.42%
2017 -9.57%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5478 seconds.